درباره این اپیزود

انگلیسی
ایالات متحده آمریکا

رونوشت 🔗

جستجوی اپیزودهای گذشته

اپیزودهای قبلی Proactive - Interviews for investors را جستجو کن.

قسمت های دیگر در این پادکست

Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) CEO Anthony Tennyson spoke with Proactive's Stephen Gunnion about a US patent allowance covering ketamine-based treatments for behavioural addictions and the commercial opportunities it opens up. The method-of-use patent covers ketamine, including bo…
1911 Gold Corporation CEO Shaun Heinrichs joined Steve Darling from Proactive to discuss additional assay results from the company's ongoing underground infill and delineation drilling program at the True North Gold Project in Manitoba, where exploration is focused on strengthening mineral resource…
Nano One Materials Corp Chief Operating Officer Denis Geoffroy joined Steve Darling from Proactive to provide an update on the company's Candiac Facility expansion, production plans and ongoing commercial discussions with potential customers. Geoffroy said the expansion project at Candiac was comp…
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to discuss a proposed transaction involving the company's wholly owned subsidiary, SkinJect, which has entered into a non-binding letter of intent with an undisclosed special purpose acquisition company (SPAC) for a potential bu…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Proactive است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.